p53 is an important regulator of cell cycle progression and apoptosis, and inactivation of p53 is associated with tumorigenesis. Although p53 exerts many of its effects through regulation of transcription, this protein is also found in association with ribosomes and several mRNAs have been identified that are translationally controlled in a p53-dependent manner. We have utilized murine erythroleukemic cells that express a temperature-sensitive p53 protein to determine whether p53 also functions at the level of translation. The data presented here demonstrate that p53 causes a rapid decrease in translation initiation. Analysis of several potential mechanisms for regulating protein synthesis shows that p53 has selective effects on the phosphorylation of the eIF4E-binding protein, 4E-BP1, and the activity of the p70 ribosomal protein S6 kinase. These data provide evidence that modulation of translational activity constitutes a further mechanism by which the growth inhibitory effects of p53 may be mediated.
Introduction
The tumor suppressor protein p53 is a key regulator of cell cycle progression and apoptosis (for reviews see Arrowsmith, 1999; Kaelin, 1999; Vousden, 2000) . Inactivating mutations of p53 have been found with high frequency in a broad spectrum of tumors and inhibition of p53 is central to the transforming function of several viral oncoproteins (Hollstein et al., 1991; Neil et al, 1997) . Primarily, p53 functions as a transcription factor controlling expression of genes that affect the cell cycle, induce DNA repair or regulate apoptosis (Arrowsmith, 1999; Kaelin, 1999; Vousden, 2000) . It also regulates the activity of RNA polymerases I and III, which transcribe rRNA and tRNA respectively, potentially affecting the synthesis of components of the translational apparatus (Chesnekov et al., 1996; Cairns and White, 1998; Budde and Grummt, 1999; Zhai and Comai, 2000) . Furthermore, p53 can associate with ribosomes (Fontoura et al., 1997) and affect the translation of several mRNAs, including those encoding p21 waf1 , cdk4 and fibroblast growth factor-2, as well as p53 itself (Fu et al., 1996; Gorospe et al., 1998; Miller et al., 2000; Galy et al., 2001) . However, it remains to be established whether p53 has a general effect upon translational regulation.
The protein that recognizes the m 7 GTP 'cap' at the 5'-terminus of all cellular mRNAs, eIF4E, is a primary target for translational regulation (Raught et al., 2000) . This protein is phosphorylated by the Mnk1 kinase, which is activated by the Erk and p38 members of the MAP kinase family (Fukunaga and Hunter, 1997; Waskiewicz et al., 1997 Waskiewicz et al., , 1999 . Such phosphorylation has been reported to enhance the cap-binding activity of eIF4E (Minich et al., 1994) and may stimulate protein synthesis, although recent data have challenged these ideas (Knauf et al., 2001; McKendrick et al., 2001) . The ability of eIF4E to participate in protein synthesis also depends on its availability to interact with the large initiation factor eIF4G. This interaction is inhibited by association of eIF4E with the small 4E-binding proteins (4E-BPs) (Lawrence and Raught and Gingras, 1999; Raught et al., 2000) . The latter are also targets for phosphorylation, and such modification causes release of the 4E-BPs from eIF4E (Raught et al., 2000) . The best studied 4E-BP (4E-BP1) becomes phosphorylated as a result of activation of signaling pathways involving members of the phosphoinositide 3-kinase (PI3k)-related (mTOR and ATM) and PKC families of protein kinases (Brunn et al., 1997; Kumar et al., 2000a) . Rates of translation of mRNAs encoding several cell cycle-related proteins, including ornithine decarboxylase, c-myc, ribonucleotide reductase and cyclin D1, are increased in cells that overexpress eIF4E, and eIF4E overexpression stimulates cells to enter the cycle and/or undergo oncogenic transformation (Fagan et al., 1991; Rosenwald et al., 1993; De Benedetti et al., 1994; Rousseau et al., 1996a; Abid et al., 1999) . Conversely, enforced expression of 4E-BP1 or inhibition of its phosphorylation by rapamycin treatment inhibits cell proliferation and can increase the susceptibility of cells to apoptosis (Rousseau et al., 1996b; Beretta et al., 1996; Tee and Proud, 2000) . This indicates that regulation of capdependent translational initiation is important for growth control. Consistent with this, the phosphorylation of eIF4E and the 4E-BPs is enhanced in response to agents which induce cell proliferation (Lawrence and Raught et al., 2000) .
Growth inhibitory signals also target the translational apparatus. Dephosphorylation of 4E-BP1 occurs in cells deprived of growth or survival factors or essential nutrients such as amino acids or glucose, as well as in cells exposed to DNA damaging agents and pro-apoptotic stimuli (Hara et al., 1998; Tee and Proud, 2000; Raught et al., 2000; Jeffrey et al., 2002) (M Hatzoglou, personal communication). In the case of growth factors, regulation of the phosphorylation of 4E-BP1 involves changes in the activity of mTOR, usually under the control of the PI3k/protein kinase B (Akt) pathway (Raught et al., 2000 . In contrast, in amino acid-starved cells, the level of tRNA charging appears to regulate mTOR activity by a PI3k-independent mechanism (Ibioshi et al., 1999; Nave et al., 1999; Kimball et al., 1999; Pham et al., 2000; Anthony et al., 2001) . Translational repression in growth-inhibited cells is also mediated by phosphorylation of the a subunit of initiation factor eIF2, the protein that binds the initiator Met-tRNA (Hershey and Merrick, 2000) . This phosphorylation results in the sequestration by eIF2 of its GTP-exchange protein eIF2B, thus limiting the recycling of eIF2 between successive rounds of initiation (Hinnebusch, 2000) . Recently a number of pro-apoptotic signals have been shown to affect translation factor phosphorylation. For example, eIF2a phosphorylation occurs rapidly (in some cases transiently) following death receptor activation and 4E-BP is dephosphorylated following exposure of cells to etoposide (Tee and Proud, 2000) , staurosporine (Tee and Proud, 2001) or TNFa family members (Jeffrey et al., 2002) . It is likely that these regulatory events play a role in the early decrease in translation rate seen in cells undergoing apoptosis .
Expression and activation of wild-type p53 in p53(7) cell lines induces a cell cycle block and can result in cell death by apoptosis (Arrowsmith, 1999; Kaelin, 1999; Vousden, 2000) . However the effects of p53 on translation under these conditions have not previously been investigated. The experiments described in this study have utilized a murine erythroleukemia (MEL) cell line expressing a temperature-sensitive (ts) p53 mutant (Val 135 ) to investigate p53-dependent translational regulation. This p53 mutant is inactive at 388C but acquires a wild-type conformation at 328C (Johnson et al., 1993) . As a control we employed cells containing another p53 mutant (Pro 190 ) which is inactive at both temperatures. Our results indicate that activation of p53 (Val 135 ) at 328C causes a rapid decrease in the overall translation rate due primarily to inhibition of polypeptide chain initiation. These effects are associated with the dephosphorylation of 4E-BP1, an increase in the association of eIF4E with 4E-BP1 and a decrease in the association of eIF4E with eIF4G. The time course of 4E-BP1 dephosphorylation parallels the p53-induced increase in expression of the cdk inhibitor, p21 waf1 , demonstrating the effect to be proximal to the activation of p53. In addition, the activity of the ribosomal protein S6 kinase, p70S6k, is inhibited by p53. In contrast, the phosphorylation of neither eIF4E nor eIF2a is affected. These data suggest that the effects of p53 on translation are mediated either by control of mTOR itself or through a parallel pathway that also targets mTOR-sensitive translational regulators.
Results
To determine the effect of p53 activation on translation Val 135 and Pro 190 cells that had been grown at 388C were shifted to 328C. In the former cells at the permissive temperature p53 becomes activated and the cells cease to proliferate; they also begin to undergo apoptosis, which is detectable by 16 -24 h (Johnson et al., 1993 (Figure 1b ). This was associated with a significant increase in 80S ribosomes, which we have previously demonstrated to be translationally inactive in MEL cells (Hensold et al., 1996) . This shift in ribosomes from translating polysomes to translationally inactive complexes indicates a defect in polypeptide chain initiation. Consistent with this observation, ribosomal protein (rp)L26 mRNA could be seen to shift out of polysomes and into translationally inactive sub-polysomal complexes in the Val 135 cells at 328C (Figure 1b) , demonstrating that the decrease in polysome content was due to an effect on translation initiation and not to a decrease in the amount of mRNA available to be translated. In contrast, in cells expressing the temperature-insensitive mutant (Pro 190 ) there was relatively little change in distribution of ribosomes in the gradient and only a minimal decrease in association of rpL26 mRNA with polysomes.
To establish the time of onset of the translation effect, amino acid incorporation rates were measured at earlier times following the shift to 328C. While both the (Hinnebusch, 2000; Clemens et al., 2000) . To assess whether this mechanism was involved in the effect of p53 on overall translation, eIF2a phosphorylation was measured following the temperature shift by immunoblotting cell extracts with antibodies that recognize total eIF2a or only the Ser 51 -phosphorylated form of this protein. The results demonstrate that, at the times investigated, phosphorylation of eIF2a was not affected by incubation of Val 135 cells at the permissive temperature ( Figure 2a) . Thus, the effect of p53 on translation does not appear to be mediated by eIF2a phosphorylation. To determine if p53 affects the function of initiation factors involved in mRNA cap recognition, phosphorylation of eIF4E and 4E-BP1 was assessed following the shift to 328C. The extent of phosphorylation of eIF4E was determined using a phospho-specific antibody; phosphorylation of 4E-BP1 was assessed by gel shift, since the phosphorylated b and g forms of the protein migrate more slowly in standard SDS-containing gels (Lin et al., 1995) . While phosphorylation of eIF4E was unaffected by p53 activation (Figure 2a The kinetics of 4E-BP1 dephosphorylation were compared with those for the induction of the expression of p21 waf1 , a direct transcriptional target of p53 action (El-Deiry et al., 1993) . As demonstrated in Figure 2b , the temperature shift had no effect on expression of p21 in the Pro 190 cells. In contrast, in the Val 135 cells increased p21 expression was detectable by 40 -80 min, becoming even more pronounced by 120 min of incubation at the temperature permissive for p53 activity. These results demonstrate again that the inhibition of protein synthesis is closely related in time to the onset of p53 activity, confirming that the translational apparatus is an early target of p53 action.
To determine whether the observed change in 4E-BP1 phosphorylation has functional consequences for initiation factor interactions, eIF4E and its associated proteins were isolated by affinity chromatography on m 7 GTP-Sepharose. As demonstrated in Figure 3a , both the unphosphorylated (a) and partially phosphorylated (b) forms of 4E-BP1 are preferentially recovered on this matrix, due to their binding to eIF4E. At 328C the association of 4E-BP1 with eIF4E was much greater in the Val 135 cells than in the Pro 190 cells (Figure 3a) . Conversely, using the same samples the recovery of eIF4G on m 7 -GTP Sepharose was lower from the Val 135 cells than the Pro 190 cells (Figure 3b ). Thus, p53 activation results in decreased phosphorylation of 4E-BP1 together with enhanced binding of the latter to eIF4E and impaired binding of eIF4G to eIF4E.
The phosphorylation of 4E-BP1 is dependent at least in part on the kinase mTOR (Raught et al., 2000 Gingras et al., 2001) . This enzyme has other substrates in addition to 4E-BP1 and we therefore investigated whether activation of p53 affects the activity of another mTOR-regulated protein, the ribosomal protein S6 kinase (p70S6k). p70S6k activity was assessed by The preceding data demonstrate that activation of p53 results, respectively, in a decrease in phosphorylation and activity of two substrates of mTOR, 4E-BP1 and p70S6k, suggesting that p53 might affect the activity of mTOR itself. We attempted to determine the state of activity of mTOR by measuring the extent of phosphorylation of Ser 2448 in this protein (Scott et al., 1998) after immunoprecipitation. However, we were unable to reliably address this with the available reagents. Therefore we investigated whether p53 affects activity of the upstream pathway involving PI3-kinase and Akt (protein kinase B) that is known to influence mTOR function (Raught et al., 2000) . To assess Akt activity an in vitro kinase assay was performed using GSK-3 as a substrate. Following a 2 h incubation of cells at 328C both the level and activity of Akt were decreased, but to a similar extent in the Val 135 and the Pro 190 cell lines ( Figure 5 ). Thus the decrease in Akt activity appears to be due to the lower temperature per se and is not specific to the activation of p53. This suggests that any potential effect of p53 on mTOR is not due to interference with the PI3-kinase/Akt signaling pathway. Indeed this pathway has been shown to be required for other effects of p53 such as ) mutant p53 protein were incubated at the permissive (328C) or nonpermissive temperature (388C) for 4 h. As a control, an aliquot of cells grown at 388C was incubated with the PI3-k inhibitor, LY90210 (PI3-k is necessary for Akt activation). Akt was immunoprecipitated from the cell extracts and its kinase activity assessed by incubating purified glycogen synthase kinase 3 (GSK3) with the immunoprecipitates. Phosphorylation of GSK3 was determined by SDS -PAGE and immunoblotting with a phosphospecific GSK3 antiserum (upper panels). The amount of Akt recovered was determined by immunoblotting (lower panels) p53 and regulation of translation initiation LE Horton et al p21 induction (Mitsuuchi et al., 2000) . In addition, activation of p53 did not affect Erk phosphorylation in the MEL cells (data not shown) suggesting that p53 also does not affect signaling from this pathway.
Discussion
The data presented here provide evidence that, in addition to its role as a transcriptional regulator and pro-apoptotic protein, p53 also affects translation. Since protein synthesis is essential for cell growth (Brooks, 1977) , this provides an additional mechanism by which p53 can inhibit cell cycle progression. The effect of p53 on translation is accompanied by changes in the phosphorylation and activity of 4E-BP1 and the ribosomal protein S6 kinase, p70S6k. These effects are selective since phosphorylation of eIF4E and eIF2a, two other well-characterized targets for translational regulation, is not similarly affected. Since 4E-BP phosphorylation and p70S6k activation are both regulated by mTOR this suggests that p53 may affect the activity of mTOR, although other forms of regulation cannot be excluded.
The decrease in translation in cells with activated p53 is primarily due to a decrease in the initiation rate, since polysomes are reduced in number, concurrent with an increase in non-translating ribosomes. Consistent with this, rpL26 mRNA shifts from polysomes into non-translating subpolysomal complexes following incubation of the Val 135 cells at the permissive temperature. The mRNA encoding rpL26 has a 5'-terminal oligopyrimidine tract (TOP) and S6 phosphorylation has been proposed to regulate translation of mRNAs with this feature (Jefferies et al., 1994; Terada et al., 1994; Fumagalli and Thomas, 2000) . As demonstrated here, p70S6k activity is impaired in cells containing active p53. This suggests that p53 may inhibit ribosomal biogenesis via the translational repression of ribosomal protein mRNAs, as well as by other mechanisms such as inhibition of RNA polymerase I activity (Cairns and White, 1998; Budde and Grummt, 1999) . These results provide further evidence that the production of new ribosomes, a process necessary for cell cycle progression (Terada et al., 1995; Volarevic et al., 2000) is a target for regulation by p53.
Activation of p53 results in a rapid decrease in the extent of phosphorylation of 4E-BP1. As shown in other systems this is a likely cause of the increased binding of 4E-BP1 to eIF4E, concomitant with decreased binding of eIF4G to eIF4E (see Raught et al., 2000 for reviews). Such changes potentially can inhibit cap-dependent translation and may also specifically impair the translation of mRNAs that are required for progression through the G1 phase of the cell cycle. Similar changes mediated by inhibition of mTOR by rapamycin have been shown to result in inhibition of the G1 to S phase transition (Thomas and Hall, 1997; Schmelzle and Hall, 2000) . Conversely, increasing the availability of eIF4E by microinjection into quiescent 3T3 cells results in entry of the cells into S phase (Smith et al., 1990) , overexpression of eIF4E is associated with the promotion of cell transformation, and high levels of eIF4E characterize the malignant phenotypes of many human tumors (reviewed in Zimmer et al., 2000) . Consistent with this, 4E-BP1 has been demonstrated to act as a tumor suppressor gene product (Rousseau et al., 1996b) . Thus it is likely that the effects of p53 on 4E-BP1 phosphorylation and cap-dependent translation contribute to the ability of this protein to arrest cell growth and to function as a tumor suppressor. Translational regulation should therefore be added to the many mechanisms, including the transcriptional up-regulation of growth inhibitory and pro-apoptotic genes, by which p53 exerts its effects.
In contrast to the changes in phosphorylation of 4E-BP1 and the activity of p70S6k following p53 activation, the phosphorylation of eIF2a and eIF4E was not affected by incubation of the Val 135 cells at the permissive temperature. This is distinct from the situation seen in growth factor-deprived or nutrientstarved cells (Raught et al., 2000) and suggests that p53 only activates a sub-set of the physiological responses associated with these cellular stresses. A similarly specific effect on 4E-BP1, without any changes in eIF2a or eIF4E phosphorylation, has been seen in cells responding to DNA damage induced by etoposide (Tee and Proud, 2000) . An association between p53 and the eIF2a kinase PKR has been reported (Cuddihy et al., 1999) , but there is no evidence for the activation of PKR as a consequence of this. While we cannot rule out the possibility that transient phosphorylation of eIF2a follows activation of p53, as has been seen in cells responding to stimulation of the pro-apoptotic Fas (CD95) receptor , no enhancement of eIF2a phosphorylation is evident at a time when overall protein synthesis is clearly inhibited.
Although our data suggest that p53 could affect the activity of mTOR, the lack of effect on Akt activity (as well as Erk phosphorylation) implies that p53 does not interfere with certain well established signaling pathways, such as those emanating from growth factor receptors, that can result in mTOR activation. In this respect our data differ from those recently described by Stambolic et al. (2001) who showed a temperaturesensitive p53-specific dephosphorylation of Akt, without any change in the total level of Akt, after 8 h at the permissive temperature. This effect was attributed to induction by p53 of PTEN, a negative regulator of the PI3-kinase/Akt pathway. However in our system PTEN expression did not change following the temperature shift (L Horton, unpublished observations). The discrepancies between our data and those of Stambolic et al. (2001) may reflect cell-type-specific or time-dependent differences in the regulation of PTEN and Akt by p53 in different systems. There is a precedent for Akt-independent regulation of mTOR in that amino acid deprivation affects the activity of the latter via a pathway that is distinct from the PI3-kinase/Akt cascade (Ibioshi et al., 1999; Nave et al., . Thus it is possible that p53 affects mTOR by a similar mechanism to that regulated by amino acid starvation, but the nature of this pathway remains to be established. An alternative means of regulating 4E-BP1 phosphorylation involves the inhibition of mTOR activity by c-Abl-mediated phosphorylation of mTOR on tyrosine residues (Kumar et al., 2000b) . C-Abl has been shown to associate with p53 and to enhance the DNA-binding ability of the latter (Yuan et al., 1996; Nie et al., 2000) , and it has been suggested that c-Abl and p53 may exhibit some overlapping or redundant functions (Wang et al., 2000) . Whether c-Abl is responsible for the effect of p53 on mTOR activity reported here remains to be determined. C-Abl and p53 are also downstream mediators of the actions of the ATM protein, a kinase which itself has recently been shown to phosphorylate 4E-BP1 (Yang and Kastan, 2000) . However, the phosphorylation of 4E-BP1 by ATM is associated with activation of protein synthesis (by insulin) rather than inhibition, and the site in 4E-BP1 modified by ATM (Ser 111 ) is not alone sufficient to cause any change in the extent of association of the 4E-binding protein with eIF4E Mothe-Satney et al., 2000) . In contrast, our own findings would be consistent with a scenario in which, under conditions where ATM is activated by DNA damage, a p53-dependent inhibition of the mTORmediated phosphorylation of 4E-BP1 may occur, and this is associated with translational down-regulation. However the possibility cannot be excluded that p53 regulates 4E-BP1 phosphorylation and p70S6k activity by a parallel pathway that does not involve mTOR. A number of studies suggest that 4E-BP1 (which is phosphorylated on multiple sites) is also a substrate for protein kinases other than mTOR (Heesom et al., 1998 (Heesom et al., , 2001 Gingras et al., 1999; Yang and Kastan, 2000; Jiang et al., 2001) .
The time courses of the changes in overall translation rate and 4E-BP1 dephosphorylation are similar to that of the increase in p21 waf1 expression. The latter protein is a direct transcriptional target of p53 and its rapid induction suggests that even times as short as 1 -2 h at 328C are sufficient for p53 to induce new gene expression at the transcriptional level. Although p53 can associate with ribosomes (Fontoura et al., 1997) and is able to translationally repress the synthesis of proteins such as cdk4 and FGF-2 directly (Miller et al., 2000; Galy et al., 2001) , it is also possible that mTOR activity, 4E-BP1 phosphorylation and/or overall protein synthesis are regulated by factors that are transcriptionally induced by p53. We have been unable to test this directly since transcriptional inhibitors such as DRB and actinomycin D themselves affect p53 function and/or the state of phosphorylation of 4E-BP1 (Loreni et al., 2000; David-Pfeuty et al., 2001) . Further studies, for example using mutant forms of p53 which are deficient in transcriptional transactivation or selectively defective in the ability to induce different sets of genes (Haupt et al., 1995; Ding et al., 2000; Kokontis et al., 2001) , will therefore be required to establish the mechanism by which p53 controls translation as part of its function as a key factor in growth regulation and tumorigenesis. (Johnson et al., 1993) . The cells were grown in Dulbecco's modified Eagle's medium containing 12% fetal bovine serum and 2 mM glutamine at 388C. p53 was activated in the Val 135 cells by incubation at 328C for the indicated times. The Pro 190 cells were treated identically. To determine the time course of p53 activation, the effect of the temperature shift on expression of the p53-induced gene product p21 waf1 was determined by immunoblotting, as described below, using antibodies obtained from NeoMarkers (Fremont, CA, USA).
Materials and methods

Materials
Determination of amino acid incorporation rates
The overall rate of protein synthesis in intact cells was measured by the incorporation of [ 35 S]methionine into trichloroacetic acid-insoluble material. After pulse-labeling with 10 -15 mCi/ml of the radioactive amino acid (in the presence of the normal level of methionine in the cell culture medium), the cells were briefly centrifuged, washed once in cold phosphate-buffered saline (PBS), dissolved in 0.3 M NaOH and precipitated with 10% trichloroacetic acid in the presence of 0.5 mg bovine serum albumin carrier protein.
The precipitates were filtered, washed with 5% trichloroacetic acid and industrial methylated spirit, and the radioactivity determined by scintillation counting.
Sucrose gradient fractionation of ribosomes
Cytoplasmic extracts were prepared from cells under either normal growing conditions (388C) or at 15 h following shift to the permissive temperature (328C), using previously described methods (Merrick and Hensold, 2000) . The extracts were fractionated by centrifugation through 10 -50% buffered sucrose gradients for 4 h at 27 000 r.p.m. in an SW28.1 rotor. Fractions were collected with continuous UV monitoring (254 nm) and RNA was recovered from the fractions by phenol and chloroform extraction and ethanol precipitation. The distribution of mRNA for the ribosomal protein L26 in the gradient fractions was determined by p53 and regulation of translation initiation LE Horton et al Northern blotting, as previously described (Hensold et al., 1996) .
Determination of translation factor modifications
Translation factor modifications were analysed by immunoblotting of cell extracts prepared at the indicated times following shift to the permissive temperature. To prepare extracts, 5610 6 cells were washed in ice cold PBS and lysed in 200 ml of Buffer A (50 mM Mops/KOH, pH 7.2, 50 mM NaCl, 50 mM b-glycerophosphate, 50 mM NaF, 2 mM EGTA, 5 mM EDTA, 2 mM Benzamidine, 7 mM 2-mercaptoethanol), containing 1.5% (v/v) NP40 and 1.5% (v/v) Triton X-100. The lysates were centrifuged at 15 000 r.p.m. for 3 min at 48C in a cooled microcentrifuge, and the supernatants frozen in liquid nitrogen and stored at 7708C. Lysate proteins were solubilized in SDS sample buffer, separated by electrophoresis in SDS-polyacrylamide gels and transferred to PVDF membranes by electroblotting. Initiation factors were identified by immunoblotting, using antisera to eIF4E (a gift from Dr S Morley, University of Sussex), eIF2a (Scorsone et al., 1987) and 4E-BP1 (Zymed). Phosphorylation status was determined by use of phosphospecific antibodies to eIF4E (gift from Dr S Morley) and eIF2a (Biosource) or by gel shift analysis (for 4E-BP1), as indicated in the text. Bound antibodies were detected using secondary antibodies conjugated to either horse-radish peroxidase or alkaline phosphatase.
Isolation of eIF4E and associated proteins by m 7 -GTPSepharose chromatography eIF4E and associated proteins were recovered by affinity chromatography with m 7 GTP-Sepharose. Cell extracts (containing 170 mg of protein) were added to 50 ml of 50% (v/v) m 7 GTP-Sepharose 4B resin in Buffer A and incubated for 25 min at 48C on an Eppendorf tube shaker. The beads and bound proteins were then isolated by centrifugation in a micro-centrifuge at 48C and washed three times in 200 ml of Buffer A. The proteins were recovered from the beads by boiling in SDS sample buffer and analysed by SDSpolyacrylamide gel electrophoresis and immunoblotting.
In vitro protein kinase assays
The activity of p70S6k was assessed by an in vitro protein kinase assay. Cells were washed three times in ice-cold PBS and the cell pellets lysed by incubation for 25 min on ice in MLB (250 mM NaCl, 5 mM EDTA, 1 mM dithiothreitol, 50 mM MOPS, 0.1% IGEPAL CA-630, pH 7.0) containing both protease inhibitors (2.5 mg/ml leupeptin, 2.5 mg/ml aprotinin, 50 mg/ml PMSF) and phosphatase inhibitors (10 mM NaF, 5 mM Na 4 P 2 O 7 , 1 mM Na 3 VO 4 and 10 mM bglycerophosphate). Lysates were clarified by centrifugation for 10 min at 13 000 r.p.m. in a refrigerated microcentrifuge. p70S6k was immunoprecipitated from the cleared lysates by incubation for 4 h at 48C with 20 ml of an 80% slurry of protein A-Sepharose coupled to a rabbit polyclonal antip70S6k IgG raised against a synthetic carboxy-terminal peptide (a gift from Dr D Templeton, Case Western Reserve University). The immunoprecipitates were washed three times with MLB containing protease and phosphatase inhibitors, then with MLB (plus inhibitors) containing 2 M lithium chloride, and finally with 1 mM dithiothreitol, 50 mM Tris, pH 7.4. The wash in lithium chloride removes a contaminating kinase activity commonly found in p70S6k immunoprecipitates.
In vitro kinase assays were performed on the immunoprecipitates by adding 20 ml of kinase buffer (20 mM MgCl 2 , 1 mM dithiothreitol, 20 mM ATP, 10 mCi [g-32 P]-ATP, 40 mM Tris, pH 7.4) and 2 mg of rabbit 40S ribosomal subunits (a gift from Dr W Merrick, Case Western Reserve University) and incubating at room temperature for 30 min. Reactions were terminated by adding an equal volume of 26 SDS sample buffer and the proteins were separated by electrophoresis in 12.5% polyacrylamide gels. The proteins were electroblotted to membranes and the radiolabeled protein detected with a Packard Instant Imager.
Akt (protein kinase B) activity was also assessed by an in vitro kinase assay, using methodology and reagents provided by Cell Signaling Technologies. Briefly, Akt was immunoprecipitated from cell extracts and enzyme activity assessed by using glycogen synthase kinase-3 (GSK-3) as a substrate. Following the kinase reaction the extent of GSK phosphorylation was assessed by immunoblotting, using a phosphospecific anti-GSK antibody. The results were visualized by chemiluminescence.
